In addition to the familial NETs, genetic aberrations in MEN1, ATRX/DAXX, or mTOR pathway, and TP53 have also been noticed in sporadic pancreatic NETs [27]. This evidence concerns the gene MTOR and pancreatic neuroendocrine tumor.